EastWest Bioscience announced the appointment of two new independent Directors, Paul Mandl and Jeff Bierman, to the Board. Both these new board members will help to ensure the Company is well-equipped to efficiently execute its expansion into the US and EU. Scott Reeves, previously Chair of Board, is voluntarily stepping into the role of Secretary. Douglas Horne, who served as an independent on the Company's board since March 2017 has resigned from the board for health reasons. Paul Mandl brings to the board extensive international trade and international supply chain management experience, based on over 30 years of commercial and technical experience. His work resume spans 47 countries over 5 continents with a strong focus on the European model of regulatory harmonization predominantly in the Agrifood sector. Douglas Horne has voluntarily resigned from his position as a Director of the Company due to health reasons. He was appointed to the Company's board in March 2017 and made important contributions to the development of the Company's retail and manufacturing strategy.